Fundies. English
Segment disclosures
Company overviewSema4 Holdings Corp.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
50 dimension combinations 364 retained observations 16 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · All Other Segments
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 758000 | USD | 20260504 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 4451000 | USD | 20260223 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260504 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3157000 | USD | 20260223 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8190000 | USD | 20260223 | Open filing evidence |
Operating Segments · Gene Dx
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=wgs:GeneDxMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 101496000 | USD | 20260504 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 423088000 | USD | 20260223 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 114697000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 303596000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 101784000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 188899000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 87115000 | USD | 20260504 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 302293000 | USD | 20260223 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 76622000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 207007000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 68924000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 130385000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 61461000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 194376000 | USD | 20260223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 50350000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 136269000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 45226000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 85919000 | USD | 20240730 | Open filing evidence |
Operating Segments · Legacy Sema4
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=wgs:LegacySema4Member| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 252000 | USD | 20241029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2803000 | USD | 20241029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1590000 | USD | 20240730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2551000 | USD | 20240730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 961000 | USD | 20240429 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8190000 | USD | 20240223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2953000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 8879000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 3480000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 5926000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 2446000 | USD | 20240429 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 112460000 | USD | 20240223 | Open filing evidence |
Product And Service Other · All Other Segments
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 192000 | USD | 20260504 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 3424000 | USD | 20260223 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260504 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260223 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260223 | Open filing evidence |
Product And Service Other · Gene Dx
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember;us-gaap:StatementBusinessSegmentsAxis=wgs:GeneDxMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 763000 | USD | 20260504 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 7447000 | USD | 20260223 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1503000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 4820000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1961000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 3317000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1356000 | USD | 20260504 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3293000 | USD | 20260223 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | -544000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1849000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1075000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2393000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1318000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6912000 | USD | 20260223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1348000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4708000 | USD | 20241029 | Open filing evidence |
Product And Service Other · Legacy Gene Dx
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember;us-gaap:StatementBusinessSegmentsAxis=wgs:LegacyGeneDxMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 2071000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 3360000 | USD | 20230808 | Open filing evidence |
Product And Service Other · Legacy Sema4
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember;us-gaap:StatementBusinessSegmentsAxis=wgs:LegacySema4Member| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 1717000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2348000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 908000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 908000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20250430 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250430 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240730 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20230316 | Open filing evidence |
Product And Service Other · Other
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember;us-gaap:StatementBusinessSegmentsAxis=wgs:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250220 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20250220 | Open filing evidence |
Diagnostic Test Institutional Customers · All Other Segments
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestInstitutionalCustomersMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 566000 | USD | 20260504 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1027000 | USD | 20260223 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260504 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260223 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260223 | Open filing evidence |
Diagnostic Test Institutional Customers · Gene Dx
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestInstitutionalCustomersMember;us-gaap:StatementBusinessSegmentsAxis=wgs:GeneDxMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 15528000 | USD | 20260504 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 69045000 | USD | 20260223 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 17545000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 53529000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 18380000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 35984000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 17604000 | USD | 20260504 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 65115000 | USD | 20260223 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 17415000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 50784000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 16695000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 33369000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 16674000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 59497000 | USD | 20260223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 15720000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 47528000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 15748000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 31808000 | USD | 20240730 | Open filing evidence |
Diagnostic Test Institutional Customers · Legacy Gene Dx
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestInstitutionalCustomersMember;us-gaap:StatementBusinessSegmentsAxis=wgs:LegacyGeneDxMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 15748000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 31808000 | USD | 20230808 | Open filing evidence |
Diagnostic Test Institutional Customers · Legacy Sema4
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestInstitutionalCustomersMember;us-gaap:StatementBusinessSegmentsAxis=wgs:LegacySema4Member| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 329000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 606000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20250430 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250430 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240429 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 5370000 | USD | 20230316 | Open filing evidence |
Diagnostic Test Institutional Customers · Other
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestInstitutionalCustomersMember;us-gaap:StatementBusinessSegmentsAxis=wgs:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250220 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20250220 | Open filing evidence |
Diagnostic Test · All Other Segments
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 566000 | USD | 20260504 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1027000 | USD | 20260223 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260504 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3157000 | USD | 20260223 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8190000 | USD | 20260223 | Open filing evidence |
Diagnostic Test · Gene Dx
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestMember;us-gaap:StatementBusinessSegmentsAxis=wgs:GeneDxMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 100733000 | USD | 20260504 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 415641000 | USD | 20260223 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 113194000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 298776000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 99823000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 185582000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 85759000 | USD | 20260504 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 299000000 | USD | 20260223 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 77166000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 205158000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 67849000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 127992000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 60143000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 187464000 | USD | 20260223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 49002000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 131561000 | USD | 20241029 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 114874000 | USD | 20240223 | Open filing evidence |
Diagnostic Test · Legacy Sema4
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestMember;us-gaap:StatementBusinessSegmentsAxis=wgs:LegacySema4Member| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 329000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 606000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20250430 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 252000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2803000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1590000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2551000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 961000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8190000 | USD | 20240223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2953000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 8879000 | USD | 20241029 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 112460000 | USD | 20240223 | Open filing evidence |
Diagnostic Test · Other
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestMember;us-gaap:StatementBusinessSegmentsAxis=wgs:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 3157000 | USD | 20250220 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8190000 | USD | 20250220 | Open filing evidence |
Diagnostic Test Self Pay · All Other Segments
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestSelfPayMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260504 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260223 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260504 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260223 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | -36000 | USD | 20260223 | Open filing evidence |
Diagnostic Test Self Pay · Gene Dx
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestSelfPayMember;us-gaap:StatementBusinessSegmentsAxis=wgs:GeneDxMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 286000 | USD | 20260504 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1361000 | USD | 20260223 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 629000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1064000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 339000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 435000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 96000 | USD | 20260504 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2343000 | USD | 20260223 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 460000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1743000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 692000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1283000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 591000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1702000 | USD | 20260223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 457000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1232000 | USD | 20241029 | Open filing evidence |
Diagnostic Test Self Pay · Legacy Gene Dx
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestSelfPayMember;us-gaap:StatementBusinessSegmentsAxis=wgs:LegacyGeneDxMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 314000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 775000 | USD | 20230808 | Open filing evidence |
Diagnostic Test Self Pay · Legacy Sema4
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestSelfPayMember;us-gaap:StatementBusinessSegmentsAxis=wgs:LegacySema4Member| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20250430 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | -36000 | USD | 20240223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 3000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 3000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | -5000 | USD | 20240429 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 6356000 | USD | 20240223 | Open filing evidence |
Diagnostic Test Self Pay · Other
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestSelfPayMember;us-gaap:StatementBusinessSegmentsAxis=wgs:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250220 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | -36000 | USD | 20250220 | Open filing evidence |
Diagnostic Test Third Party Insurance · All Other Segments
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestThirdPartyInsuranceMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260504 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260223 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260504 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3157000 | USD | 20260223 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8226000 | USD | 20260223 | Open filing evidence |
Diagnostic Test Third Party Insurance · Gene Dx
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestThirdPartyInsuranceMember;us-gaap:StatementBusinessSegmentsAxis=wgs:GeneDxMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 84919000 | USD | 20260504 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 345235000 | USD | 20260223 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 95020000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 244183000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 81104000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 149163000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 68059000 | USD | 20260504 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 231542000 | USD | 20260223 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 59291000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 152631000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 50462000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 93340000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 42878000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 126265000 | USD | 20260223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 32825000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 82801000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 27093000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 49976000 | USD | 20240730 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 72890000 | USD | 20240223 | Open filing evidence |
Diagnostic Test Third Party Insurance · Legacy Sema4
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestThirdPartyInsuranceMember;us-gaap:StatementBusinessSegmentsAxis=wgs:LegacySema4Member| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20250430 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 252000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2803000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1590000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2551000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 961000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8226000 | USD | 20240223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2950000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 8876000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 3480000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 5926000 | USD | 20240730 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 100734000 | USD | 20240223 | Open filing evidence |
Diagnostic Test Third Party Insurance · Other
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=wgs:DiagnosticTestThirdPartyInsuranceMember;us-gaap:StatementBusinessSegmentsAxis=wgs:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 3157000 | USD | 20250220 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8226000 | USD | 20250220 | Open filing evidence |
All Other Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 758000 | USD | 20260504 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 4451000 | USD | 20260223 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260504 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3157000 | USD | 20260223 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8190000 | USD | 20260223 | Open filing evidence |
Gene Dx
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:GeneDxMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 101496000 | USD | 20260504 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 423088000 | USD | 20260223 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 114697000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 303596000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 101784000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 188899000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 87115000 | USD | 20260504 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 302293000 | USD | 20260223 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 76622000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 207007000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 68924000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 130385000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 61461000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 194376000 | USD | 20260223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 50350000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 136269000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 45226000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 85919000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 40693000 | USD | 20240429 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 122234000 | USD | 20240223 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 45581000 | USD | 20231103 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 71716000 | USD | 20231103 | Open filing evidence |
Gene Dx · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:GeneDxMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 61461000 | USD | 20240429 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 194376000 | USD | 20240223 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 40693000 | USD | 20240429 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 122234000 | USD | 20240223 | Open filing evidence |
Gene Dx · Product And Service Other
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:GeneDxMember;srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 1075000 | USD | 20240730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2393000 | USD | 20240730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1318000 | USD | 20240429 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6912000 | USD | 20240223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1348000 | USD | 20231103 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4708000 | USD | 20231103 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2071000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 3360000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1289000 | USD | 20240429 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 7360000 | USD | 20240223 | Open filing evidence |
Gene Dx · Diagnostic Test Institutional Customers
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:GeneDxMember;srt:ProductOrServiceAxis=wgs:DiagnosticTestInstitutionalCustomersMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 16674000 | USD | 20240429 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 59497000 | USD | 20240223 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 16060000 | USD | 20240429 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 40754000 | USD | 20240223 | Open filing evidence |
Gene Dx · Diagnostic Test
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:GeneDxMember;srt:ProductOrServiceAxis=wgs:DiagnosticTestMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 67849000 | USD | 20240730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 127992000 | USD | 20240730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 60143000 | USD | 20240429 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 49002000 | USD | 20231103 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 131561000 | USD | 20231103 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 43155000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 82559000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 39404000 | USD | 20240429 | Open filing evidence |
Gene Dx · Diagnostic Test Self Pay
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:GeneDxMember;srt:ProductOrServiceAxis=wgs:DiagnosticTestSelfPayMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 692000 | USD | 20240730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1283000 | USD | 20240730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 591000 | USD | 20240429 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1702000 | USD | 20240223 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 314000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 775000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 466000 | USD | 20240429 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1230000 | USD | 20240223 | Open filing evidence |
Gene Dx · Diagnostic Test Third Party Insurance
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:GeneDxMember;srt:ProductOrServiceAxis=wgs:DiagnosticTestThirdPartyInsuranceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 42878000 | USD | 20240429 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 32825000 | USD | 20231103 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 82801000 | USD | 20231103 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 22878000 | USD | 20240429 | Open filing evidence |
Gene Dx Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:GeneDxSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 114440000 | USD | 20260803 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 216694000 | USD | 20260803 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 102692000 | USD | 20260803 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 189807000 | USD | 20260803 | Open filing evidence |
Legacy Gene Dx
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:LegacyGeneDxMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 45226000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 85919000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 40693000 | USD | 20230509 | Open filing evidence |
Legacy Gene Dx · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:LegacyGeneDxMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 45226000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 85919000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 40693000 | USD | 20230509 | Open filing evidence |
Legacy Gene Dx · Product And Service Other
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:LegacyGeneDxMember;srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 1289000 | USD | 20230509 | Open filing evidence |
Legacy Gene Dx · Diagnostic Test Institutional Customers
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:LegacyGeneDxMember;srt:ProductOrServiceAxis=wgs:DiagnosticTestInstitutionalCustomersMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 16060000 | USD | 20230509 | Open filing evidence |
Legacy Gene Dx · Diagnostic Test
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:LegacyGeneDxMember;srt:ProductOrServiceAxis=wgs:DiagnosticTestMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 43155000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 82559000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 39404000 | USD | 20230509 | Open filing evidence |
Legacy Gene Dx · Diagnostic Test Self Pay
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:LegacyGeneDxMember;srt:ProductOrServiceAxis=wgs:DiagnosticTestSelfPayMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 466000 | USD | 20230509 | Open filing evidence |
Legacy Gene Dx · Diagnostic Test Third Party Insurance
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:LegacyGeneDxMember;srt:ProductOrServiceAxis=wgs:DiagnosticTestThirdPartyInsuranceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 27093000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 49976000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 22878000 | USD | 20230509 | Open filing evidence |
Legacy Sema4
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:LegacySema4Member| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-07-01 – 2025-09-30 | 2046000 | USD | 20251028 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2954000 | USD | 20251028 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 908000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 908000 | USD | 20250729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20250430 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 252000 | USD | 20251028 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2803000 | USD | 20251028 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1590000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2551000 | USD | 20250729 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 961000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8190000 | USD | 20240223 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2953000 | USD | 20241029 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 8879000 | USD | 20241029 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 3480000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 5926000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 2446000 | USD | 20240429 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 112460000 | USD | 20240223 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 37653000 | USD | 20231103 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 101628000 | USD | 20231103 | Open filing evidence |
Legacy Sema4 · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:LegacySema4Member;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 2446000 | USD | 20230509 | Open filing evidence |
Legacy Sema4 · Product And Service Other
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:LegacySema4Member;srt:ProductOrServiceAxis=us-gaap:ProductAndServiceOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 0 | USD | 20240429 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20240223 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240429 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20240223 | Open filing evidence |
Legacy Sema4 · Diagnostic Test Institutional Customers
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:LegacySema4Member;srt:ProductOrServiceAxis=wgs:DiagnosticTestInstitutionalCustomersMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 0 | USD | 20240223 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230509 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 5370000 | USD | 20240223 | Open filing evidence |
Legacy Sema4 · Diagnostic Test
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:LegacySema4Member;srt:ProductOrServiceAxis=wgs:DiagnosticTestMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 1590000 | USD | 20240730 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2551000 | USD | 20240730 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 961000 | USD | 20240429 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 3480000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 5926000 | USD | 20240730 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 2446000 | USD | 20240429 | Open filing evidence |
Legacy Sema4 · Diagnostic Test Self Pay
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:LegacySema4Member;srt:ProductOrServiceAxis=wgs:DiagnosticTestSelfPayMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | -5000 | USD | 20230509 | Open filing evidence |
Legacy Sema4 · Diagnostic Test Third Party Insurance
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:LegacySema4Member;srt:ProductOrServiceAxis=wgs:DiagnosticTestThirdPartyInsuranceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 961000 | USD | 20240429 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 3480000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 5926000 | USD | 20230808 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 2451000 | USD | 20240429 | Open filing evidence |
Other
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=wgs:OtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 3157000 | USD | 20250220 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8190000 | USD | 20250220 | Open filing evidence |